Christmas and New Year closure - Our office will be closed from 3:00PM, Wednesday 20th December 2024(AEDST), with last orders being processed by 10:00am that day. We’ll be back on Monday, 6th January 2025 at 9:00am. You’ll still be able to place orders online during the office closure period, and we will process all orders from 6thof January priority base, Please be aware that there will be delays in processing orders placed during the closure period. For all urgent matters, please email: info@ayurorganic.com.au We wish you all Merry Christmas And Happy New Year!.
Search
Close this search box.

Shathavari Capsules 100

(67)

$39.95

Shathavari Capsules Ectract racemosus has also been used successfully by some Ayurvedic practitioners for nervous disorders

Out of stock

Notify Me When Stock Is Available

SHATAVARI VEG CAPSULES 

Asparagus recemosus

Shathavari Capsules – Asparagus racemosus (Shathavri) is traditionally used in Ayurvedic Medicine as women tonic. Traditionally used in Ayurvedic Medicine for pitta balance, promotes digestion and supports female reproductive system.

Traditionally in Ayurvedic medicine it is used as galactagogue, means helps in promoting breast milk.

Indications

Traditionally used in Ayurveda for Pitta balance

Traditionally used in Ayurveda for Digestive Health

Traditionally used in Ayurvedic Medicine to support female reproduction.

Traditionally used in Ayurvedic Medicine for relief for menstrual irregularities.

Promote general health and wellbeing.

Warnings
Store below 30 degrees

Keep out of reach of children.

Do not expose to direct sunlight.

Drink Plenty water

Bottle sealed for your protection.

In case of allergies, please stop using and seek the help of your healthcare practitioner.

Dose:

250mg of equivalent to 1000mg of dry herb

References.

Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review. Asian Pac J Trop Dis. 2013;3(3):242-251. doi:10.1016/S2222-1808(13)60049-3

Summary: Asparagus racemosus, belongs to family Liliaceae and known as Satawar, Satamuli. Commonly used part is root as a medicine. Clinically used as women tonic and galactagogue.

Bopana N, Saxena S. Asparagus racemosus–ethnopharmacological evaluation and conservation needs. J Ethnopharmacol. 2007 Mar 1;110(1):1-15. doi: 10.1016/j.jep.2007.01.001. Epub 2007 Jan 4. PMID: 17240097.

Sumamry: Asparagus racemosus Willd. (Asparagaceae) is an important medicinal plant of tropical and subtropical India. Its medicinal usage has been reported in the Indian and British Pharmacopoeias and in traditional systems of medicine such as Ayurveda, Unani and Siddha. Asparagus racemosus is mainly known for its phytoestrogenic properties.

Goyal RK, Singh J, Lal H. Asparagus racemosus–an update. Indian J Med Sci. 2003 Sep;57(9):408-14. PMID: 14515032.

Summary: Asparagus racemosus (Shatavari) is recommended in Ayurvedic texts for prevention and treatment of gastric ulcers, dyspepsia and as a galactogogue. A. racemosus has also been used successfully by some Ayurvedic practitioners for nervous disorders, inflammation, liver diseases and certain infectious diseases. However, no scientific proof justifying uses of root extract of A. racemosus is available so far. Recently few reports are available demonstrating beneficial effects of alcoholic and water extracts of the root of A. racemosus in some clinical conditions and experimentally induced diseases, e.g. galactogogue effect, antihepatotoxic and immunomodulatory activities. The present article includes the detailed exploration of pharmacological properties of the root extract of A. racemosus reported so far.

Dose based:

Gautam M, Saha S, Bani S, Kaul A, Mishra S, Patil D, Satti NK, Suri KA, Gairola S, Suresh K, Jadhav S, Qazi GN, Patwardhan B. Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity: implications for immunoadjuvant potential. J Ethnopharmacol. 2009 Jan 21;121(2):241-7. doi: 10.1016/j.jep.2008.10.028. Epub 2008 Nov 8. PMID: 19038322.

Results: Treatment with ARE (100mg/(kg b.w.p.o.)) resulted in significant increase of CD3(+) and CD4/CD8(+) percentages suggesting its effect on T cell activation. ARE treated animals showed significant up-regulation of Th1 (IL-2, IFN-g) and Th2 (IL-4) cytokines suggesting its mixed Th1/Th2 adjuvant activity. Consistent to this, ARE also showed higher antibody titres and DTH responses. ARE, in combination with LPS, Con A or SRBC, produced a significant proliferation suggesting effect on activated lymphocytes.

Weight .2 kg
Size

60, 100

You may also like…